GLP-T is a 39-amino-acid synthetic peptide that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This first-in-class “twincretin” features a C20 fatty di-acid moiety for extended duration of action. Research demonstrates significant effects on metabolic parameters, glycemic control, and body composition.
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
This product is supplied as a lyophilized powder with purity ≥98% as determined by reverse-phase HPLC. Lot-specific certificates of analysis (CoA) including mass spectrometric confirmation of molecular identity are available upon request.
For research applications, the lyophilized peptide is typically reconstituted in sterile water or an aqueous buffer (e.g., PBS, pH 7.4). A small volume of dilute acetic acid (0.1–1%) may aid initial solubilization. Working aliquots should be prepared and stored at −80°C to minimize repeated freeze-thaw degradation. All reconstitution procedures should follow the researcher’s institutional protocols.
The lyophilized peptide should be stored at −20°C, protected from light and moisture. Under these conditions, stability is maintained for up to 24 months. Repeated freeze-thaw cycles of reconstituted material should be avoided to preserve integrity.
Scientific research has identified several key areas where GLP-T shows promising applications.
These research findings represent ongoing studies and should not be interpreted as medical claims or recommendations.
$75.00
